Washington: The US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have determined that the recommended pause regarding the use of Johnson & Johnson COVID-19 Vaccine in the US should be lifted and use of the vaccine should resume.
Health authorities in the United States on April 14 proposed a halt on the vaccine following instances of severe blood clots among a handful of the millions of Americans who received the vaccine.
The news came shortly after an expert panel recommended lifting the pause because the shots benefits exceeded possible dangers.
Comments are closed.